IDL Biotech AB operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IDL Biotech AB with three other
pharmaceutical manufacturers in Europe:
sales of 2.08 million Euro [US$2.29 million]
of which 75%
was Product sales (own and third party)),
(33.86 million Swedish Kronor [US$3.83 million]
Asit Biotech SA
based in Belgium
(4,000.00 Euro [US$4,390.76 ]
IDL Biotech AB reported sales of SEK 28.52 million (US$3.23 million)
December of 2015.
increase of 8.0%
versus 2014, when the company's sales were SEK 26.40 million.
This was the fourth straight year of sales growth at IDL Biotech AB.